Ionis Pharmaceuticals (IONS)
Develops antisense medicines through owned launches and pharmaceutical partnerships.
$43.34
vs last close−2.41 (−5.28%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
−$1.00
Revenue estimate
$181.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Nov '26
Reported−$0.66−$0.75$0.86−$0.61−$1.41−$0.56−$0.69Pending
Estimate−$1.09−$1.11$0.27−$1.15−$1.24−$0.85−$1.09−$1.00
Surprise+39.4%+32.4%+218.5%+47.0%−14.0%+34.1%+36.7%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Nov '26
Reported$226.6M$131.6M$452.0M$156.7M$203.0M$246.0M$268.0MPending
Estimate$131.1M$150.6M$131.7M$153.6M$156.1M$195.6M$189.1M$181.6M
Surprise+72.8%−12.6%+243.1%+2.1%+30.1%+25.8%+41.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.32 | — | — |
| Sep 2027 | −$0.37 | — | — |
| Jun 2027 | −$0.77 | — | — |
| Mar 2027 | −$0.85 | — | — |
| Dec 2026 | −$0.90 | — | — |
| Nov 2026 | −$1.00 | — | — |
| Jul 2026 | −$1.09 | −$0.69 | +36.7% |
| Apr 2026 | −$0.85 | −$0.56 | +34.1% |
| Feb 2026 | −$1.24 | −$1.41 | −14.0% |
| Oct 2025 | −$1.15 | −$0.61 | +47.0% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.32 | — | — | $387.0M | — | — | — |
| Sep 2027 | −$0.37 | — | — | $354.5M | — | — | — |
| Jun 2027 | −$0.77 | — | — | $272.9M | — | — | — |
| Mar 2027 | −$0.85 | — | — | $254.1M | — | — | — |
| Dec 2026 | −$0.90 | — | — | $253.3M | — | — | — |
| Nov 4, 2026 | −$1.00 | — | — | $181.6M | — | — | — |
| Jul 29, 2026 | −$1.09 | −$0.69 | +36.7% | $189.1M | $268.0M | +41.7% | −2.3% |
| Apr 29, 2026 | −$0.85 | −$0.56 | +34.1% | $195.6M | $246.0M | +25.8% | +4.3% |
| Feb 25, 2026 | −$1.24 | −$1.41 | −14.0% | $156.1M | $203.0M | +30.1% | −5.3% |
| Oct 29, 2025 | −$1.15 | −$0.61 | +47.0% | $153.6M | $156.7M | +2.1% | −2.3% |
| Jul 30, 2025 | |||||||
| Apr 30, 2025 | |||||||
| Feb 19, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 21, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 22, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 4, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 4, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Feb 28, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 4, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 4, 2015 |